A Californian rice and barley ingredient developer has been
criticized by organic and sustainable agriculture advocate, the
Center for Food Safety (CFS), over attempts to introduce specialist
GM proteins into the US food supply.
Dutch biotech group Pharming is stepping up talks with nutritional
companies in the US to bring its recombinant human lactoferrin to
the market, after submitting safety data to the Food and Drug
Administration.
Dutch biotech company Pharming said today that it has been granted
a Japanese patent on its recombinant human lactoferrin (rhLF), an
ingredient being targeted at nutraceutical and food makers.